Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros











Intervalo de año de publicación
1.
Int J Nanomedicine ; 18: 6153-6183, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37915750

RESUMEN

Carbon-based nanomaterials (CBNs) are a category of nanomaterials with various systems based on combinations of sp2 and sp3 hybridized carbon bonds, morphologies, and functional groups. CBNs can exhibit distinguished properties such as high mechanical strength, chemical stability, high electrical conductivity, and biocompatibility. These desirable physicochemical properties have triggered their uses in many fields, including biomedical applications. In this review, we specifically focus on applying CBNs as scaffolds in tissue engineering, a therapeutic approach whereby CBNs can act for the regeneration or replacement of damaged tissue. Here, an overview of the structures and properties of different CBNs will first be provided. We will then discuss state-of-the-art advancements of CBNs and hydrogels as scaffolds for regenerating various types of human tissues. Finally, a perspective of future potentials and challenges in this field will be presented. Since this is a very rapidly growing field, we expect that this review will promote interdisciplinary efforts in developing effective tissue regeneration scaffolds for clinical applications.


Asunto(s)
Nanoestructuras , Ingeniería de Tejidos , Humanos , Hidrogeles/química , Carbono , Andamios del Tejido/química
2.
Nanomaterials (Basel) ; 13(16)2023 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-37630958

RESUMEN

Biosensors based on graphene field-effect transistors (G-FET) for detecting COVID-19 spike S protein and its receptor ACE2 were reported. The graphene, directly synthesized on SiO2/Si substrate by microwave plasma-enhanced chemical vapor deposition (MW-PECVD), was used for FET biosensor fabrication. The commercial graphene, CVD-grown on a copper substrate and subsequently transferred onto a glass substrate, was applied for comparison purposes. The graphene structure and surface morphology were studied by Raman scattering spectroscopy and atomic force microscope. Graphene surfaces were functionalized by an aromatic molecule PBASE (1-pyrenebutanoic acid succinimidyl ester), and subsequent immobilization of the receptor angiotensin-converting enzyme 2 (ACE2) was performed. A microfluidic system was developed, and transfer curves of liquid-gated FET were measured after each graphene surface modification procedure to investigate ACE2 immobilization by varying its concentration and subsequent spike S protein detection. The directly synthesized graphene FET sensitivity to the receptor ACE2, evaluated in terms of the Dirac voltage shift, exceeded the sensitivity of the transferred commercial graphene-based FET. The concentration of the spike S protein was detected in the range of 10 ag/mL up to 10 µg/mL by using a developed microfluidic system and measuring the transfer characteristics of the liquid-gated G-FETs. It was found that the shift of the Dirac voltage depends on the spike S concentration and was 27 mV with saturation at 10 pg/mL for directly synthesized G-FET biosensor, while for transferred G-FET, the maximal shift of 70 mV was obtained at 10 µg/mL with a tendency of saturation at 10 ng/mL. The detection limit as low as 10 ag/mL was achieved for both G-FETs. The sensitivity of the biosensors at spike S concentration of 10 pg/mL measured as relative current change at a constant gate voltage corresponding to the highest transconductance of the G-FETs was found at 5.6% and 8.8% for directly synthesized and transferred graphene biosensors, respectively. Thus, MW-PECVD-synthesized graphene-based biosensor demonstrating high sensitivity and low detection limit has excellent potential for applications in COVID-19 diagnostics.

3.
Virulence ; 12(1): 2247-2272, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34496717

RESUMEN

Currently, microbial biofilms have been the cause of a wide variety of infections in the human body, reaching 80% of all bacterial and fungal infections. The biofilms present specific properties that increase the resistance to antimicrobial treatments. Thus, the development of new approaches is urgent, and antimicrobial photodynamic therapy (aPDT) has been shown as a promising candidate. aPDT involves a synergic association of a photosensitizer (PS), molecular oxygen and visible light, producing highly reactive oxygen species (ROS) that cause the oxidation of several cellular components. This therapy attacks many components of the biofilm, including proteins, lipids, and nucleic acids present within the biofilm matrix; causing inhibition even in the cells that are inside the extracellular polymeric substance (EPS). Recent advances in designing new PSs to increase the production of ROS and the combination of aPDT with other therapies, especially pulsed electric fields (PEF), have contributed to enhanced biofilm inhibition. The PEF has proven to have antimicrobial effect once it is known that extensive chemical reactions occur when electric fields are applied. This type of treatment kills microorganisms not only due to membrane rupture but also due to the formation of reactive compounds including free oxygen, hydrogen, hydroxyl and hydroperoxyl radicals. So, this review aims to show the progress of aPDT and PEF against the biofilms, suggesting that the association of both methods can potentiate their effects and overcome biofilm infections.


Asunto(s)
Antiinfecciosos , Biopelículas , Fotoquimioterapia , Fármacos Fotosensibilizantes , Antiinfecciosos/farmacología , Electricidad , Matriz Extracelular de Sustancias Poliméricas , Humanos , Oxígeno , Fármacos Fotosensibilizantes/farmacología , Especies Reactivas de Oxígeno
4.
Dalton Trans ; 47(33): 11539-11553, 2018 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-30079914

RESUMEN

Three heterobimetallic complexes of formula [Ca2Cu3(mpyba)2(2-apyma)(H2O)7]·8.3H2O (1), [Sr2Cu3(mpyba)2(2-apyma)(H2O)8]·11.6H2O (2) and [Sr4.5Cu4(mpyba)4(ox)(H2O)20]·8.5H2O (3) [H4mpyba = N,N'-2,6-pyridinebis(oxamic acid), 2-apyma = 2-(6-aminopyridinyl)oxamate and ox = oxalate] have been synthesized and structurally characterized. Complexes 1 and 2 are isostructural compounds, with tricopper(ii) units having mpyba and its hydrolytic product (2-apyma) as ligands. They are interlinked through strontium(ii) (1) and calcium(ii) (2) ions to afford neutral two-dimensional networks. Two of the copper(ii) ions are five-coordinate in distorted square pyramidal (Cu3) and trigonal bipyramidal (Cu1) surroundings, whereas the other (Cu2) is six-coordinate in an elongated octahedral environment. The main difference between their structures, apart from the number of water molecules, resides in the nature of the alkaline earth cation coordinated to the oxamate fragments, Sr2+ (1)/Ca2+ (2), which exhibit eight and seven coordination, respectively. The π-π interactions and an extensive network of hydrogen bonds in 1 and 2 lead to supramolecular 3D structures. The relatively small size of their cavities, in the micropore domain, hinders the inclusion of N2 but allows CO2 adsorption (0.45 and 0.52 mmol g-1 for 1 and 2, respectively). The structure of 3 is made up of [3,3] metallacyclophane-type motifs, having the formula [Cu2(mpyba)2(H2O)2]4-. These act as tetrakis(bidentate) ligands towards the strontium(ii) ions (Sr1, Sr2 and Sr3), leading to a sheet-like polymer growing in the bc plane, which extends further along the crystallographic a axis by a bis(chelating) oxalate between the Sr1 atoms. The investigation of the magnetic properties of 1-3 in the temperature range 1.9-300 K shows the occurrence of an overall antiferromagnetic behaviour for 1 and 2 [J12 = J23 = -9.71(2) (1) and -10.81(5) cm-1 (2), with the Hamiltonian being defined as H = -J12S1·S2 - J23S2·S3 + gßH[S1 + S2 + S3], and a ferromagnetic coupling within the dicopper(ii) metallacylophane unit of 3 [J = +1.86(1) cm-1 through the Hamiltonian H = -JS1·S2 + gßH(S1 + S2)]. Simple orbital symmetry considerations (1-3) and the spin polarization mechanism (3) account for the observed magnetic properties.

5.
Virulence ; 9(1): 28-63, 2018 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-28960132

RESUMEN

Traditional methods of localizing and quantifying the presence of pathogenic microorganisms in living experimental animal models of infections have mostly relied on sacrificing the animals, dissociating the tissue and counting the number of colony forming units. However, the discovery of several varieties of the light producing enzyme, luciferase, and the genetic engineering of bacteria, fungi, parasites and mice to make them emit light, either after administration of the luciferase substrate, or in the case of the bacterial lux operon without any exogenous substrate, has provided a new alternative. Dedicated bioluminescence imaging (BLI) cameras can record the light emitted from living animals in real time allowing non-invasive, longitudinal monitoring of the anatomical location and growth of infectious microorganisms as measured by strength of the BLI signal. BLI technology has been used to follow bacterial infections in traumatic skin wounds and burns, osteomyelitis, infections in intestines, Mycobacterial infections, otitis media, lung infections, biofilm and endodontic infections and meningitis. Fungi that have been engineered to be bioluminescent have been used to study infections caused by yeasts (Candida) and by filamentous fungi. Parasitic infections caused by malaria, Leishmania, trypanosomes and toxoplasma have all been monitored by BLI. Viruses such as vaccinia, herpes simplex, hepatitis B and C and influenza, have been studied using BLI. This rapidly growing technology is expected to continue to provide much useful information, while drastically reducing the numbers of animals needed in experimental studies.


Asunto(s)
Enfermedades Transmisibles , Luciferasas , Mediciones Luminiscentes , Organismos Modificados Genéticamente/crecimiento & desarrollo , Animales , Recuento de Colonia Microbiana , Enfermedades Transmisibles/microbiología , Enfermedades Transmisibles/parasitología , Enfermedades Transmisibles/virología , Modelos Animales de Enfermedad , Microbiología de Alimentos , Genes Reporteros , Luciferasas/genética , Luciferasas/metabolismo , Organismos Modificados Genéticamente/genética
6.
Photodiagnosis Photodyn Ther ; 18: 232-235, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28359936

RESUMEN

Histoplasmosis is a respiratory and systemic disease caused by the dimorphic fungus Histoplasma capsulatum. The clinical features may vary from asymptomatic infections to disseminated severe form depending of patient immunity. The treatment of histoplasmosis can be performed with itraconazole, fluconazole, and in the disseminated forms is used amphotericin B. However, the critical side effects of amphotericin B, the cases of itraconazole therapy failure and the appearance of fluconozole-resistant strains makes necessary the search of new strategies to treat this disease. Antimicrobial photodynamic therapy (aPDT) seems to be a potential candidate once have been show efficacy to inhibit others dimorphic fungi. Although the photosensitizer (PS) chalcone aggregates in biological medium, it has antifungal activity and show a high quantum yield of ROS formation. So, the aim of this study was to obtain the experimental parameters to achieve an acceptable selective chalcone water-soluble derivatives photoinactivation of H. capsulatum comparing with fibroblastic and keratinocytes cells which are the constituents of some potential host tissues. Yeast and cells were incubated with the same chalchones concentrations and short incubation time followed by irradiation with equal dose of light. The best conditions to kill H. capsulatum selectively were very low photosensitizers concentration (1.95µgmL-1) incubated by 15min and irradiated with LED 450nm with 24Jcm-2. Key words: chalcone, Histoplasma capsulatum, aPDT, selectivity.


Asunto(s)
Antifúngicos/administración & dosificación , Chalconas/administración & dosificación , Desinfección/métodos , Histoplasma/efectos de los fármacos , Histoplasma/efectos de la radiación , Fotoquimioterapia/métodos , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/efectos de la radiación , Relación Dosis-Respuesta a Droga , Luz , Fármacos Fotosensibilizantes/administración & dosificación , Dosis de Radiación , Solubilidad , Resultado del Tratamiento , Agua/química
7.
Front Microbiol ; 8: 36, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28167935

RESUMEN

The high rates of morbidity and mortality caused by fungal infections are associated with the current limited antifungal arsenal and the high toxicity of the compounds. Additionally, identifying novel drug targets is challenging because there are many similarities between fungal and human cells. The most common antifungal targets include fungal RNA synthesis and cell wall and membrane components, though new antifungal targets are being investigated. Nonetheless, fungi have developed resistance mechanisms, such as overexpression of efflux pump proteins and biofilm formation, emphasizing the importance of understanding these mechanisms. To address these problems, different approaches to preventing and treating fungal diseases are described in this review, with a focus on the resistance mechanisms of fungi, with the goal of developing efficient strategies to overcoming and preventing resistance as well as new advances in antifungal therapy. Due to the limited antifungal arsenal, researchers have sought to improve treatment via different approaches, and the synergistic effect obtained by the combination of antifungals contributes to reducing toxicity and could be an alternative for treatment. Another important issue is the development of new formulations for antifungal agents, and interest in nanoparticles as new types of carriers of antifungal drugs has increased. In addition, modifications to the chemical structures of traditional antifungals have improved their activity and pharmacokinetic parameters. Moreover, a different approach to preventing and treating fungal diseases is immunotherapy, which involves different mechanisms, such as vaccines, activation of the immune response and inducing the production of host antimicrobial molecules. Finally, the use of a mini-host has been encouraging for in vivo testing because these animal models demonstrate a good correlation with the mammalian model; they also increase the speediness of as well as facilitate the preliminary testing of new antifungal agents. In general, many years are required from discovery of a new antifungal to clinical use. However, the development of new antifungal strategies will reduce the therapeutic time and/or increase the quality of life of patients.

8.
J Fungi (Basel) ; 3(2)2017 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-29371540

RESUMEN

Biofilm formation is an important virulence factor for pathogenic fungi. Both yeasts and filamentous fungi can adhere to biotic and abiotic surfaces, developing into highly organized communities that are resistant to antimicrobials and environmental conditions. In recent years, new genera of fungi have been correlated with biofilm formation. However, Candida biofilms remain the most widely studied from the morphological and molecular perspectives. Biofilms formed by yeast and filamentous fungi present differences, and studies of polymicrobial communities have become increasingly important. A key feature of resistance is the extracellular matrix, which covers and protects biofilm cells from the surrounding environment. Furthermore, to achieve cell-cell communication, microorganisms secrete quorum-sensing molecules that control their biological activities and behaviors and play a role in fungal resistance and pathogenicity. Several in vitro techniques have been developed to study fungal biofilms, from colorimetric methods to omics approaches that aim to identify new therapeutic strategies by developing new compounds to combat these microbial communities as well as new diagnostic tools to identify these complex formations in vivo. In this review, recent advances related to pathogenic fungal biofilms are addressed.

9.
Artículo en Inglés | MEDLINE | ID: mdl-27896220

RESUMEN

Pathogenic fungi have developed many strategies to evade the host immune system. Multiple escape mechanisms appear to function together to inhibit attack by the various stages of both the adaptive and the innate immune response. Thus, after entering the host, such pathogens fight to overcome the immune system to allow their survival, colonization and spread to different sites of infection. Consequently, the establishment of a successful infectious process is closely related to the ability of the pathogen to modulate attack by the immune system. Most strategies employed to subvert or exploit the immune system are shared among different species of fungi. In this review, we summarize the main strategies employed for immune evasion by some of the major pathogenic fungi.


Asunto(s)
Hongos/inmunología , Hongos/patogenicidad , Interacciones Huésped-Patógeno , Evasión Inmune , Animales , Humanos
10.
Photodiagnosis Photodyn Ther ; 10(4): 647-50, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24284122

RESUMEN

The effective transport of photosensitizers (PS) across the membrane and the intracellular accumulation of PS are the most crucial elements in antimicrobial photodynamic therapy (aPDT). However, due to the morphological complexity of Gram-negative bacteria the penetration of PS is limited, especially hydrophobic PS. Electroporation (EP) could increase the effectiveness of aPDT, by promoting the formation of transient pores that enhance the permeability of the bacterial membrane to PS. In this study we evaluated the combination of aPDT mediated by the hydrophobic PS, hypericin and EP (aPDT/EP) against Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli. These bacteria were exposed to light (590 nm) in the presence of hypericin (4 µM), following electroporation. The results showed that aPDT/EP inactivated 3.67 logs more E. coli and 2.65 logs more S. aureus than aPDT alone. Based on these results we suggest that EP can potentiate the aPDT effect.


Asunto(s)
Desinfección/métodos , Electroporación/métodos , Escherichia coli/efectos de los fármacos , Perileno/análogos & derivados , Fotoquimioterapia/métodos , Staphylococcus aureus/efectos de los fármacos , Antracenos , Antibacterianos/administración & dosificación , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Apoptosis/efectos de la radiación , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Supervivencia Celular/efectos de la radiación , Escherichia coli/fisiología , Escherichia coli/efectos de la radiación , Interacciones Hidrofóbicas e Hidrofílicas , Perileno/administración & dosificación , Perileno/química , Fármacos Fotosensibilizantes/administración & dosificación , Fármacos Fotosensibilizantes/química , Staphylococcus aureus/fisiología , Staphylococcus aureus/efectos de la radiación , Resultado del Tratamiento
11.
Curr Opin Pharmacol ; 13(5): 731-62, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24060701

RESUMEN

Owing to the worldwide increase in antibiotic resistance, researchers are investigating alternative anti-infective strategies to which it is supposed microorganisms will be unable to develop resistance. Prominent among these strategies, is a group of approaches which rely on light to deliver the killing blow. As is well known, ultraviolet light, particularly UVC (200-280 nm), is germicidal, but it has not been much developed as an anti-infective approach until recently, when it was realized that the possible adverse effects to host tissue were relatively minor compared to its high activity in killing pathogens. Photodynamic therapy is the combination of non-toxic photosensitizing dyes with harmless visible light that together produce abundant destructive reactive oxygen species (ROS). Certain cationic dyes or photosensitizers have good specificity for binding to microbial cells while sparing host mammalian cells and can be used for treating many localized infections, both superficial and even deep-seated by using fiber optic delivered light. Many microbial cells are highly sensitive to killing by blue light (400-470 nm) due to accumulation of naturally occurring photosensitizers such as porphyrins and flavins. Near infrared light has also been shown to have antimicrobial effects against certain species. Clinical applications of these technologies include skin, dental, wound, stomach, nasal, toenail and other infections which are amenable to effective light delivery.


Asunto(s)
Antiinfecciosos/administración & dosificación , Luz , Fotoquimioterapia , Fármacos Fotosensibilizantes/administración & dosificación , Animales , Infecciones Bacterianas/tratamiento farmacológico , Farmacorresistencia Microbiana , Humanos , Micosis/tratamiento farmacológico , Virosis/tratamiento farmacológico
12.
Expert Rev Anti Infect Ther ; 11(7): 669-93, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23879608

RESUMEN

Microbial biofilms are responsible for a variety of microbial infections in different parts of the body, such as urinary tract infections, catheter infections, middle-ear infections, gingivitis, caries, periodontitis, orthopedic implants, and so on. The microbial biofilm cells have properties and gene expression patterns distinct from planktonic cells, including phenotypic variations in enzymic activity, cell wall composition and surface structure, which increase the resistance to antibiotics and other antimicrobial treatments. There is consequently an urgent need for new approaches to attack biofilm-associated microorganisms, and antimicrobial photodynamic therapy (aPDT) may be a promising candidate. aPDT involves the combination of a nontoxic dye and low-intensity visible light which, in the presence of oxygen, produces cytotoxic reactive oxygen species. It has been demonstrated that many biofilms are susceptible to aPDT, particularly in dental disease. This review will focus on aspects of aPDT that are designed to increase efficiency against biofilms modalities to enhance penetration of photosensitizer into biofilm, and a combination of aPDT with biofilm-disrupting agents.


Asunto(s)
Biopelículas/efectos de la radiación , Farmacorresistencia Microbiana , Fotoquimioterapia , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/radioterapia , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Terapia Combinada , Humanos , Pruebas de Sensibilidad Microbiana , Micosis/tratamiento farmacológico , Micosis/radioterapia , Especies Reactivas de Oxígeno , Tetrapirroles/química , Tetrapirroles/uso terapéutico
13.
FEMS Microbiol Rev ; 37(6): 955-89, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23802986

RESUMEN

Reactive oxygen species (ROS) can attack a diverse range of targets to exert antimicrobial activity, which accounts for their versatility in mediating host defense against a broad range of pathogens. Most ROS are formed by the partial reduction in molecular oxygen. Four major ROS are recognized comprising superoxide (O2•-), hydrogen peroxide (H2O2), hydroxyl radical (•OH), and singlet oxygen ((1)O2), but they display very different kinetics and levels of activity. The effects of O2•- and H2O2 are less acute than those of •OH and (1)O2, because the former are much less reactive and can be detoxified by endogenous antioxidants (both enzymatic and nonenzymatic) that are induced by oxidative stress. In contrast, no enzyme can detoxify •OH or (1)O2, making them extremely toxic and acutely lethal. The present review will highlight the various methods of ROS formation and their mechanism of action. Antioxidant defenses against ROS in microbial cells and the use of ROS by antimicrobial host defense systems are covered. Antimicrobial approaches primarily utilizing ROS comprise both bactericidal antibiotics and nonpharmacological methods such as photodynamic therapy, titanium dioxide photocatalysis, cold plasma, and medicinal honey. A brief final section covers reactive nitrogen species and related therapeutics, such as acidified nitrite and nitric oxide-releasing nanoparticles.


Asunto(s)
Antibacterianos , Bacterias , Miel , Infecciones/terapia , Neoplasias/terapia , Especies Reactivas de Oxígeno , Animales , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Antioxidantes/metabolismo , Antioxidantes/farmacología , Bacterias/efectos de los fármacos , Bacterias/metabolismo , Catálisis , Miel/análisis , Humanos , Oxigenoterapia Hiperbárica , Estrés Oxidativo , Fotoquimioterapia , Gases em Plasma , Especies de Nitrógeno Reactivo/metabolismo , Especies de Nitrógeno Reactivo/uso terapéutico , Especies Reactivas de Oxígeno/química , Especies Reactivas de Oxígeno/metabolismo , Especies Reactivas de Oxígeno/uso terapéutico
14.
Expert Opin Drug Discov ; 8(3): 331-55, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23293893

RESUMEN

INTRODUCTION: Discovery of novel drugs, treatments, and testing of consumer products in the field of dermatology is a multi-billion dollar business. Due to the distressing nature of many dermatological diseases, and the enormous consumer demand for products to reverse the effects of skin photodamage, aging, and hair loss, this is a very active field. AREAS COVERED: In this paper, we will cover the use of animal models that have been reported to recapitulate to a greater or lesser extent the features of human dermatological disease. There has been a remarkable increase in the number and variety of transgenic mouse models in recent years, and the basic strategy for constructing them is outlined. EXPERT OPINION: Inflammatory and autoimmune skin diseases are all represented by a range of mouse models both transgenic and normal. Skin cancer is mainly studied in mice and fish. Wound healing is studied in a wider range of animal species, and skin infections such as acne and leprosy also have been studied in animal models. Moving to the more consumer-oriented area of dermatology, there are models for studying the harmful effect of sunlight on the skin, and testing of sunscreens, and several different animal models of hair loss or alopecia.


Asunto(s)
Modelos Animales de Enfermedad , Enfermedades de la Piel , Animales , Enfermedades Autoinmunes/tratamiento farmacológico , Descubrimiento de Drogas , Inflamación/tratamiento farmacológico , Enfermedades de la Piel/tratamiento farmacológico
15.
Biotechnol Adv ; 31(5): 607-31, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22951919

RESUMEN

Phototherapy can be used in two completely different but complementary therapeutic applications. While low level laser (or light) therapy (LLLT) uses red or near-infrared light alone to reduce inflammation, pain and stimulate tissue repair and regeneration, photodynamic therapy (PDT) uses the combination of light plus non-toxic dyes (called photosensitizers) to produce reactive oxygen species that can kill infectious microorganisms and cancer cells or destroy unwanted tissue (neo-vascularization in the choroid, atherosclerotic plaques in the arteries). The recent development of nanotechnology applied to medicine (nanomedicine) has opened a new front of advancement in the field of phototherapy and has provided hope for the development of nanoscale drug delivery platforms for effective killing of pathological cells and to promote repair and regeneration. Despite the well-known beneficial effects of phototherapy and nanomaterials in producing the killing of unwanted cells and promoting repair and regeneration, there are few reports that combine all three elements i.e. phototherapy, nanotechnology and, tissue repair and regeneration. However, these areas in all possible binary combinations have been addressed by many workers. The present review aims at highlighting the combined multi-model applications of phototherapy, nanotechnology and, reparative and regeneration medicine and outlines current strategies, future applications and limitations of nanoscale-assisted phototherapy for the management of cancers, microbial infections and other diseases, and to promote tissue repair and regeneration.


Asunto(s)
Nanomedicina/métodos , Fototerapia/métodos , Medicina Regenerativa/métodos , Animales , Humanos , Fotoquimioterapia/métodos , Regeneración/fisiología
16.
Artículo en Portugués | LILACS | ID: lil-658489

RESUMEN

O aparecimento de uma grande variedade de micro-organismos patogênicos resistentes aos antimicrobianos tem resultado tanto no aumento do índice de doenças quanto no aumento do índice de mortalidade, ambos provocados por infecções facilmente tratadas no passado. Assim, tornou-se urgente a necessidade de desenvolver novos procedimentos de intervenção a fim de promover a inviabilização do crescimento microbiano. A Inativação Fotodinâmica de micro-organismos é uma alternativa promissora no combate de infecções localizadas de micro-organismos. Basicamente esse mecanismo envolve a combinação sinérgica de um fotossensibilizador, oxigênio molecular e luz visível de comprimento de onda adequado para produzir espécies reativas de oxigênio, que causam oxidação dos componentes da célula levando-a à morte. A principal vantagem dessa técnica é o fato de não haver desenvolvimento de resistência ao tratamento pelos micro-organismos, devido ao grande número de alvos possíveis por parte dos radicais de oxigênio. Este trabalho faz uma comparação entre inativação fotodinâmica de micro-organismos e a ação dos antimicrobianos.


The appearance of a large variety of antimicrobial-resistant pathogenic microorganisms has led to increased rates of disease and mortality caused by infections that were easily treated in the past. Hence,338Fotoinativação versus antimicrobianosRev Ciênc Farm Básica Apl., 2012;33(3):331-340there is an urgent need to develop new procedures to prevent microbial growth. Photodynamic inactivation of microorganisms is a promising alternative way to fight localized microbial infections. This technique, basically, involves the synergistic combination of a photosensitizer, molecular oxygen and visible light of an appropriate wavelength, to produce highly reactive oxygen species that lead to the oxidation of several cell components and to cell inactivation. The main advantage of the technique is that, given the existence of multiple targets, there is no development of resistance. This paper aims to compare the photodynamic inactivation of microorganisms and the action of antibiotics.


Asunto(s)
Infecciones Bacterianas , Farmacorresistencia Microbiana , Fotoquimioterapia/métodos , Micosis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA